Clinical Efficacy and Mechanism of Tongxie Yaofang on Patients with IBS-D of Liver Depression and Spleen Deficiency

Si-jie YAO; Xu-rui WANG; Ming-ming ZHANG

doi:10.13422/j.cnki.syfjx.20201221

您当前的位置：

首页 >

文章列表页 >

Clinical Efficacy and Mechanism of Tongxie Yaofang on Patients with IBS-D of Liver Depression and Spleen Deficiency

Clinic | 更新时间：2020-08-11

- Clinical Efficacy and Mechanism of Tongxie Yaofang on Patients with IBS-D of Liver Depression and Spleen Deficiency
- Chinese Journal of Experimental Traditional Medical Formulae Vol. 26, Issue 12, Pages: 107-113(2020)
- 作者机构：
  
  1.彭州市中医医院，四川彭州 611930
  2.四川省人民医院，成都 610000
  3.成都中医药大学附属医院，成都 610000
- 作者简介：
- 基金信息：
- DOI：10.13422/j.cnki.syfjx.20201221
  CLC： R22;R242;R2-031;R287
- Published Online：19 March 2020，
  
  Published：20 June 2020
- 稿件说明：
移动端阅览
姚思杰,王栩芮,张明明.痛泻要方对肝郁脾虚型IBS-D患者的临床疗效及其机制[J].中国实验方剂学杂志,2020,26(12):107-113.

YAO Si-jie,WANG Xu-rui,ZHANG Ming-ming.Clinical Efficacy and Mechanism of Tongxie Yaofang on Patients with IBS-D of Liver Depression and Spleen Deficiency[J].Chinese Journal of Experimental Traditional Medical Formulae,2020,26(12):107-113.
姚思杰,王栩芮,张明明.痛泻要方对肝郁脾虚型IBS-D患者的临床疗效及其机制[J].中国实验方剂学杂志,2020,26(12):107-113. DOI： 10.13422/j.cnki.syfjx.20201221.

YAO Si-jie,WANG Xu-rui,ZHANG Ming-ming.Clinical Efficacy and Mechanism of Tongxie Yaofang on Patients with IBS-D of Liver Depression and Spleen Deficiency[J].Chinese Journal of Experimental Traditional Medical Formulae,2020,26(12):107-113. DOI： 10.13422/j.cnki.syfjx.20201221.

摘要

目的

观察痛泻要方对肝郁脾虚型肠易激综合征（irritable bowel syndrome-D，IBS-D）的临床疗效，通过比治疗前后肠道菌群变化探讨其调节脑肠交互机制。

方法

将2016年7月至2018年12月就诊的116例肝郁脾虚型IBS-D患者，随机分为观察组及对照组，各58例，观察组患者使用痛泻要方全方口服治疗，对照组患者接受匹维溴铵口服治疗，两组患者治疗周期均为4周。比较两组患者治疗前后中医证候疗效评分（traditional Chinese medicine pattern curative effect scoring system，TCM-PES），IBS生活质量问卷评分（IBS quality of life questionnaire，IBS-QOL），焦虑自评量表（self-rating anxiety scale，SAS）积分及抑郁自评量表（self-rating depression scale，SDS）积分；采用酶联免疫吸附测定（enzyme-linked immunosorbent assay，ELISA）检测患者治疗前后血浆血管活性肽（vasoactive intestinal peptide，VIP），降钙素基因相关肽（calcitonin gene related peptide，CGRP）水平；采用实时荧光定量聚合酶链式反应（quantitative Real-time，PCR）检测治疗前后患者大肠埃希菌、双歧杆菌、嗜酸乳杆菌、粪链球菌等肠道菌群变化。

结果

两组患者治疗后TCM-PES评分下降，IBS-QOL评分提高，观察组患者治疗后TCM-PES评分低于对照组，IBS-QOL评分高于对照组（

0.05）；观察组患者中医证候疗效有效率明显高于对照组（

0.05）；观察患者治疗后SAS，SDS评分明显降低，治疗后观察组患者SAS，SDS评分低于对照组（

0.05）；两组患者治疗后血浆CGRP，VIP均下降，观察组患者血浆CGRP，VIP明显低于对照组（

0.05）；两组患者治疗后大肠埃希菌均差异无统计学意义，观察组患者治疗后肠道嗜酸乳杆菌、双歧杆菌、粪链球菌较本组治疗前增长（

0.05），对照组患者治疗后肠道嗜酸乳杆菌较本组治疗前增长（

0.05），观察组患者治疗后肠道嗜酸乳杆菌、双歧杆菌、粪链球菌较对照组增长（

0.05）。

结论

中药痛泻要方可减轻肝郁脾虚型IBS-D患者腹痛、腹泻等临床症状，改善患者不良情绪，提高患者生活质量，这可能与痛泻要方改善患者肠道菌群失调，调节脑肠肽分泌，降低内脏高敏有关。

Abstract

Objective

To observe the clinical efficacy of Tongxie Yaofang on irritable bowel syndrome-D (IBS-D) of liver-stagnation and spleen-deficiency type

in order to explore its mechanism in regulating brain-intestine interaction by changing the intestinal flora before and after treatment.

Method

Totally 116 patients with IBS-D with liver stagnation and spleen deficiency who were diagnosed from July 2016 to December 2018 were randomly divided into observation group and control group

with 58 patients in each group. Observation group was treated with Tongxie Yaofang orally. Control group was treated with pivalvonium orally. Both groups were treated for 4 weeks. Scores of traditional Chinese medicine pattern curative effect scoring system (TCM-PES)

IBS quality of life questionnaire (IBS-QOL)

self-rating anxiety scale (SAS) and self-rating depression scale (SDS) of two groups were compared before and after treatment. Calcitonin gene-related peptide (CGRP) and vasoactive intestinal peptide (VIP) were detected before and after treatment by enzyme-linked immunosorbent assay (ELISA). Real-time fluorescent quantitative polymerase chain reaction(Real-time PCR) was used to detect changes in

Escherichia coli

Bifidobacteria

Lactobacillus acidophilus

and

Streptococcus faecalis

and other intestinal flora before and after treatment.

Result

TCM-PES and IBS-QOL scores of two groups were improved after treatment. TCM-PES and IBS-QOL scores of observation group were higher than those of control group (

0.05). TCM syndromes of observation group were significantly higher than those of control group (

0.05). SAS and SDS scores were significantly lower after treatment. SAS and SDS scores of observation group were lower than those of control group after treatment (

0.05). Plasma CGRP and VIP decreased after treatment. Plasma CGRP and VIP in observation group were significantly lower than those in control group (

0.05). There was no significant change in

E. coli

after treatment in two groups. After treatment

L. acidophilus

Bifidobacterium

and

S. faecalis

increased (

0.05). In control group

intestinal

L. acidophilus

increased after treatment (

0.05). The differences of intestinal

L. acidophilus

Bifidobacterium

S. faecalis

in two groups were statistically significant (

0.05).

Conclusion

TCM can alleviate clinical symptoms

such as abdominal pain and diarrhea in patients with IBS-D

improve patients' bad mood and improve their quality of life. This may be related to improvement of intestinal flora imbalance

regulation of brain intestinal peptide secretion and reduction of visceral hypersensitivity.

关键词

Keywords

references

XU X J , LIU L , YAO S K . Nerve growth factor and diarrhea-predominant irritable bowel syndrome(IBS-D）:a potential therapeutic target [J]. Biomed Biotechnol , 2016 , 17 ( 1 ): 1 - 9 .

文廷玉 , 曹砚杰 . 附子理中汤合四神丸加减治疗脾肾阳虚型腹泻型肠易激综合征 [J]. 中国实验方剂学杂志 , 2016 , 22 ( 9 ): 177 - 180 .

邓多喜 , 谭洁 , 张泓 , 等 . 针刺合募配穴对肠易激综合征大鼠结肠内脏高敏相关因子的影响 [J]. 针刺研究 , 2018 , 43 ( 8 ): 485 - 491 .

王春烨 , 包春辉 , 丁邦友 , 等 . 肠道菌群及其代谢产物在针灸调节肠易激综合征中作用概述 [J]. 世界科学技术—中医药现代化 , 2018 , 20 ( 5 ): 756 - 761 .

王鹏 , 李延青 . 肠道微生态与肠易激综合征:基础与临床 [J]. 胃肠病学 , 2019 , 24 ( 4 ): 193 - 197 .

韩建雄 , 骆成俊 , 杨波 , 等 . 马来酸曲美布汀联合谷维素治疗肠易激综合征的临床效果及安全性观察 [J]. 四川解剖学杂志 , 2019 , 27 ( 2 ): 7 - 9 .

孙凯英 , 彭莉蓉 , 王晶晶 , 等 . 美沙拉嗪联合匹维溴铵治疗肠易激综合征的疗效观察 [J]. 现代药物与临床 , 2018 , 33 ( 11 ): 2941 - 2944 .

陈敏 , 黄德铨 , 唐太春 , 等 . 痛泻要方调控BDNF mRNA表达缓解肠易激综合征腹泻大鼠内脏高敏的机制研究 [J]. 中华中医药学刊 , 2017 , 35 ( 12 ): 3095 - 3097 .

何力 , 杨力 , 凌志维 , 等 . 基于脑肠交互机制探讨肠道微生物调节IBS-D内脏高敏的研究进展 [J]. 中国实验方剂学杂志 , 2019 , 25 ( 11 ): 224 - 229 .

BRIAN E A ， FERMIN M C ， CHANG L , et al . Bowel Disodrers [J]. Gastroenterology , 2016 , 150 ( 5 ): 1393 - 1407 .

张声生 , 魏玮 , 杨俭勤 . 肠易激综合征中医诊疗专家共识意见(2017) [J]. 中医杂志 , 2017 , 58 ( 18 ): 1614 - 1620 .

中华人民共和国卫生部 . 中药新药临床研究指导原则 [M]. 北京 : 中国医药科技出版社 , 2002 : 378 - 385 .

HAHN B A , KIRCHDOERFER L J , FULLERTON S , et al . Evaluation of a new quality of life questionnaire for patients with irritable bowel syndrome [J]. Aliment Pharmacol Ther , 1997 , 11 ( 3 ): 547 - 552 .

黄芳 , 谢磊 , 徐喆 . 认知干预对慢性鼻窦炎手术患者心理健康及护理措施依从性的影响 [J]. 重庆医学 , 2017 , 46 ( 16 ): 2303 - 2304 .

石志敏 , 李雪青 , 郝丽君 , 等 . 针刺不同腧穴治疗腹泻型肠易激综合征的随机对照研究 [J]. 成都中医药大学学报 , 2017 , 40 ( 3 ): 87 - 90 .

王栩芮 , 侯长城 , 陈敏 , 等 . 黄德铨基于“情志不节”诊治肠易激综合征经验浅析 [J]. 辽宁中医杂志 , 2016 , 43 ( 6 ): 1164 - 1166 .

LIU Y , ZHANG L , WANG X , et al . Similar fecal microbiota signatures in patients with diarrhea-predominant irritable bowel syndrome and patients with depression [J]. Clin Gastroenterol Hepatol , 2016 , 14 ( 11 ): 1602 - 1611 .

CRYAN J F , DINAN T G . Mind-altering microorganisms:the impact of the gut microbiota on brain and behaviour [J]. Nat Rev Neurosci , 2012 , 13 ( 10 ): 701 - 712 .

王东旭 , 林连捷 , 林艳 , 等 . 益生菌对腹泻型肠易激综合征患者疗效及肠道菌群的影响 [J]. 中国现代医学杂志 , 2015 , 25 ( 27 ): 67 - 70 .

刘靖 . 痛泻要方治疗腹泻型肠易激综合征的疗效观察及其对肠道菌群的影响 [D]. 北京 : 中国中医科学院 , 2017 .

鄢伟伦 , 王帅帅 , 任霞 . 白术对小鼠肠道菌群调节作用的实验研究 [J]. 山东中医杂志 , 2011 , 30 ( 6 ): 417 - 419 .

叶清清 , 王雅茹 , 方伟彬 , 等 . 8味中药对肠道特征菌的调节作用研究 [J]. 广东药学院学报 , 2016 , 32 ( 3 ): 291 - 294 .

李翔 , 王丽 , 时克 , 等 . 中药防风对临床常见细菌抑制作用的实验研究 [J]. 微量元素与健康研究 , 2014 , 31 ( 1 ): 7 - 8 .

梁瑞峰 , 葛文静 , 王慧森 , 等 . 痛泻要方加减引经药防风对肠易激综合征大鼠内脏敏感性及脑肠轴不同靶点脑肠肽的影响 [J]. 中国实验方剂学杂志 , 2018 , 24 ( 2 ): 152 - 157 .

钟莹 , 戴红 , 陈金锦 . 双歧杆菌三联活菌散联合度洛西汀治疗腹泻型肠易激综合征临床疗效及对血清5-HT、脑肠肽水平的影响 [J]. 浙江中西医结合杂志 , 2018 , 28 ( 4 ): 287 - 290 .

姜华 , 邓松华 . 增液承气汤对肠道菌群失调大鼠神经肽分泌调节影响研究 [J]. 四川中医 , 2018 , 36 ( 10 ): 46 - 48 .

傅丽霞 . 双歧杆菌四联活菌片治疗腹泻型肠易激综合征患者的疗效及对血清脑肠肽水平的影响 [J]. 中国微生态学杂志 , 2017 , 29 ( 2 ): 179 - 181 .

Views

下载量

CSCD

Alert me when the article has been cited

提交

Tools

Publicity Resources

Efficacy of Jianpi Shugan Fomula on Intestinal Flora of Patients with Diarrhea Predominant Irritable Bowel Syndrome and Its Effect on Intestinal Flora

Mechanism of Paeonol in Alleviating Alcohol-induced Liver Injury in Mice Through Regulating SCFAs-GPR43/MAPK Signaling Pathway Mediated by Intestinal Flora

Effect of Huangling Jidu Xizhuo Granules on NLRP3， Intestinal Flora and Short-term Prognosis in Patients with Gout

Mechanism and Combination Therapy of Berberine in Treatment of Nonalcoholic Fatty liver Disease：A Review

Mechanisms of Intestinal Microecology in Hyperuricemia and Traditional Chinese Medicine Intervention：A Review

Related Author

Xing-xing ZHANG

Jian WU

Li-xia PEI

Yi XU

Bai YE

Shen-lin LIU

JIANG Shengnan

WU Qifeng

Related Institution

Affiliated Hospital of Nanjing University of Chinese Medicine

College of Pharmacy，Anhui University of Chinese Medicine

School of Integrated Chinese and Western Medicine，Anhui University of Chinese Medicine

Geriatric Care and Health Laboratory，Anhui University of Chinese Medicine

The First Affiliated Hospital of Anhui University of Chinese Medicine

AI问答

Postal code：100700
Tel：010-84076882 Email：syfjx_2010@188.com
Technical support is provided by Beijing Founder electronics co., LTD 京ICP备11006657号-10 京公网安备11010802024621
It is recommended to read the content of this site in Chrome&IE9+. Please switch to extreme mode in browser 360.
Cookies We use cookies to help provide and enhance our service and tailor content. By continuing, you agree to the use of cookies.

⁰